These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
439 related articles for article (PubMed ID: 29771383)
1. Relationship of fibroblast growth factor 21 with kidney function and albuminuria: multi-ethnic study of atherosclerosis. Anuwatmatee S; Allison MA; Shlipak MG; McClelland RL; Kramer H; Tang S; Hou L; Rye KA; Ong KL Nephrol Dial Transplant; 2019 Jun; 34(6):1009-1016. PubMed ID: 29771383 [TBL] [Abstract][Full Text] [Related]
2. Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA). Peralta CA; Katz R; Bonventre JV; Sabbisetti V; Siscovick D; Sarnak M; Shlipak MG Am J Kidney Dis; 2012 Dec; 60(6):904-11. PubMed ID: 22749388 [TBL] [Abstract][Full Text] [Related]
3. Low serum bicarbonate and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA). Driver TH; Shlipak MG; Katz R; Goldenstein L; Sarnak MJ; Hoofnagle AN; Siscovick DS; Kestenbaum B; de Boer IH; Ix JH Am J Kidney Dis; 2014 Oct; 64(4):534-41. PubMed ID: 24953891 [TBL] [Abstract][Full Text] [Related]
4. Relationship of fibroblast growth factor 21 with subclinical atherosclerosis and cardiovascular events: Multi-Ethnic Study of Atherosclerosis. Ong KL; Campbell S; Wu BJ; McClelland RL; Kokkinos J; Szklo M; Polak JF; Allison MA; Rye KA Atherosclerosis; 2019 Aug; 287():46-53. PubMed ID: 31212234 [TBL] [Abstract][Full Text] [Related]
5. Biological Variability of Estimated GFR and Albuminuria in CKD. Waikar SS; Rebholz CM; Zheng Z; Hurwitz S; Hsu CY; Feldman HI; Xie D; Liu KD; Mifflin TE; Eckfeldt JH; Kimmel PL; Vasan RS; Bonventre JV; Inker LA; Coresh J; Am J Kidney Dis; 2018 Oct; 72(4):538-546. PubMed ID: 30031564 [TBL] [Abstract][Full Text] [Related]
6. Contribution of cardiometabolic risk factors to estimated glomerular filtration rate decline in Indigenous Australians with and without albuminuria - the eGFR Follow-up Study. Barr EL; Barzi F; Hughes JT; Jerums G; O'Dea K; Brown AD; Ekinci EI; Jones GR; Lawton PD; Sinha A; MacIsaac RJ; Cass A; Maple-Brown LJ Nephrology (Carlton); 2018 Jul; 23(7):682-689. PubMed ID: 28503768 [TBL] [Abstract][Full Text] [Related]
7. Sugar-sweetened beverage consumption and the progression of chronic kidney disease in the Multi-Ethnic Study of Atherosclerosis (MESA). Bomback AS; Katz R; He K; Shoham DA; Burke GL; Klemmer PJ Am J Clin Nutr; 2009 Nov; 90(5):1172-8. PubMed ID: 19740973 [TBL] [Abstract][Full Text] [Related]
8. Association of Soluble TNFR-1 Concentrations with Long-Term Decline in Kidney Function: The Multi-Ethnic Study of Atherosclerosis. Bhatraju PK; Zelnick LR; Shlipak M; Katz R; Kestenbaum B J Am Soc Nephrol; 2018 Nov; 29(11):2713-2721. PubMed ID: 30287518 [TBL] [Abstract][Full Text] [Related]
9. Fibroblast Growth Factor 23: A Biomarker of Kidney Function Decline. Drew DA; Katz R; Kritchevsky S; Ix JH; Shlipak MG; Newman AB; Hoofnagle A; Fried L; Sarnak MJ; Gutierrez OM Am J Nephrol; 2018; 47(4):242-250. PubMed ID: 29621752 [TBL] [Abstract][Full Text] [Related]
10. Parallel assessment of albuminuria and plasma sTNFR1 in people with type 2 diabetes and advanced chronic kidney disease provides accurate prognostication of the risks of renal decline and death. Martin WP; Tuohy C; Doody A; Jackson S; Canavan RJ; Slattery D; Twomey PJ; McKenna MJ; le Roux CW; Docherty NG Sci Rep; 2020 Sep; 10(1):14852. PubMed ID: 32908199 [TBL] [Abstract][Full Text] [Related]
11. Chronic kidney disease, cardiovascular disease and mortality: A prospective cohort study in a multi-ethnic Asian population. Lim CC; Teo BW; Ong PG; Cheung CY; Lim SC; Chow KY; Meng CC; Lee J; Tai ES; Wong TY; Sabanayagam C Eur J Prev Cardiol; 2015 Aug; 22(8):1018-26. PubMed ID: 24857889 [TBL] [Abstract][Full Text] [Related]
13. Changes in GFR and Albuminuria in Routine Clinical Practice and the Risk of Kidney Disease Progression. Neuen BL; Weldegiorgis M; Herrington WG; Ohkuma T; Smith M; Woodward M Am J Kidney Dis; 2021 Sep; 78(3):350-360.e1. PubMed ID: 33895181 [TBL] [Abstract][Full Text] [Related]
14. Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis. ; Grams ME; Coresh J; Matsushita K; Ballew SH; Sang Y; Surapaneni A; Alencar de Pinho N; Anderson A; Appel LJ; Ärnlöv J; Azizi F; Bansal N; Bell S; Bilo HJG; Brunskill NJ; Carrero JJ; Chadban S; Chalmers J; Chen J; Ciemins E; Cirillo M; Ebert N; Evans M; Ferreiro A; Fu EL; Fukagawa M; Green JA; Gutierrez OM; Herrington WG; Hwang SJ; Inker LA; Iseki K; Jafar T; Jassal SK; Jha V; Kadota A; Katz R; Köttgen A; Konta T; Kronenberg F; Lee BJ; Lees J; Levin A; Looker HC; Major R; Melzer Cohen C; Mieno M; Miyazaki M; Moranne O; Muraki I; Naimark D; Nitsch D; Oh W; Pena M; Purnell TS; Sabanayagam C; Satoh M; Sawhney S; Schaeffner E; Schöttker B; Shen JI; Shlipak MG; Sinha S; Stengel B; Sumida K; Tonelli M; Valdivielso JM; van Zuilen AD; Visseren FLJ; Wang AY; Wen CP; Wheeler DC; Yatsuya H; Yamagata K; Yang JW; Young A; Zhang H; Zhang L; Levey AS; Gansevoort RT JAMA; 2023 Oct; 330(13):1266-1277. PubMed ID: 37787795 [TBL] [Abstract][Full Text] [Related]
15. Comparison between urine albumin-to-creatinine ratio and urine protein dipstick testing for prevalence and ability to predict the risk for chronic kidney disease in the general population (Iwate-KENCO study): a prospective community-based cohort study. Koeda Y; Tanaka F; Segawa T; Ohta M; Ohsawa M; Tanno K; Makita S; Ishibashi Y; Itai K; Omama SI; Onoda T; Sakata K; Ogasawara K; Okayama A; Nakamura M BMC Nephrol; 2016 May; 17(1):46. PubMed ID: 27169575 [TBL] [Abstract][Full Text] [Related]
16. Neighborhood Social Context and Kidney Function Over Time: The Multi-Ethnic Study of Atherosclerosis. Hicken MT; Katz R; Crews DC; Kramer HJ; Peralta CA Am J Kidney Dis; 2019 May; 73(5):585-595. PubMed ID: 30655114 [TBL] [Abstract][Full Text] [Related]
17. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study. Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612 [TBL] [Abstract][Full Text] [Related]
18. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus. Liu JJ; Pek SLT; Ang K; Tavintharan S; Lim SC; J Clin Endocrinol Metab; 2017 Oct; 102(10):3683-3691. PubMed ID: 28973352 [TBL] [Abstract][Full Text] [Related]
19. The relationship of circulating fibroblast growth factor 21 levels with incident atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis. Hui TH; McClelland RL; Allison MA; Rodriguez CJ; Kronmal RA; Heckbert SR; Michos ED; Barter PJ; Rye KA; Ong KL Atherosclerosis; 2018 Feb; 269():86-91. PubMed ID: 29351855 [TBL] [Abstract][Full Text] [Related]
20. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes. Nichols GA; Déruaz-Luyet A; Brodovicz KG; Kimes TM; Rosales AG; Hauske SJ BMC Nephrol; 2020 May; 21(1):167. PubMed ID: 32380961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]